Products - Eczema | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Rocatinlimab for treating moderate to severe atopic dermatitis in people 12 years and over [ID6565]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Delgocitinib for Chronic Hand Eczema [ID12188]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ruxolitinib for treating moderate atopic dermatitis [ID6602]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC